Loading...
•
Mar 31, 2025
agilon health Q1 2025 Earnings Report
Estimated Revenue:$1.49B
-5.4% YoY
Estimated EPS:$0.01
+20.8% YoY
Key Takeaways
agilon health reported total revenues of $1.53 billion in the first quarter of 2025. The company saw a decrease in total members on the platform compared to the previous year, primarily due to market exits, but membership growth in new markets and same geography growth partially offset this impact. Net income for the quarter was positive, a significant improvement from a net loss in the same period of the prior year.
Total revenues for Q1 2025 were $1.53 billion, a 4% decrease year-over-year.
Medicare Advantage membership reached 491,000 as of March 31, 2025.
The company reported a net income of $12 million in Q1 2025, compared to a net loss of $6 million in Q1 2024.
Gross profit for the first quarter was $51 million, down from $75 million in the prior year period.
Revenue by Segment
Forward Guidance
agilon health reaffirmed its full year 2025 earnings guidance and provided guidance for the second quarter of 2025. The guidance reflects expected Medicare Advantage and ACO Model membership, total revenues, medical margin, and Adjusted EBITDA.
Positive Outlook
- Expected Medicare Advantage membership between 490,000 and 520,000 for the full year 2025.
- Expected total revenues between $5,850 million and $6,025 million for the full year 2025.
- Expected medical margin between $275 million and $325 million for the full year 2025.
- Adjusted EBITDA contribution from ACO model is expected to be approximately $35-$40 million for fiscal year 2025.
- Part D exposure reduced to less than 30% of membership, partially offsetting Inflation Reduction Act impact.
Challenges Ahead
- Expected Medicare Advantage membership between 485,000 and 515,000 for Q2 2025, a potential decrease from Q1 end of period.
- Expected total revenues between $1,435 million and $1,505 million for Q2 2025, lower than Q1 2025 revenues.
Loading...
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...